Trade CMND anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Clearmind Medicine Inc. Common Shares (CMND) is trading at US$1.42, down 16.71% today as of Sep 4, 12:48 EDT. The company has a market capitalisation of US$2.58M. Over the past 52 weeks, CMND has traded between US$1.42 and US$524.00. On Syfe you can trade CMND with $0 commission and add it to your watchlist.
| Previous close | US$1.70 |
|---|---|
| Market cap | US$2.58M |
| 52-week range | US$1.42 – US$524.00 |
| Volume | 58.76K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Clearmind Medicine Inc. Common Shares
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Year: 2021
Clearmind Medicine Expands Global IP Portfolio With Hong Kong Patent Filing
Jul 20, 12:33 PM · MT Newswires
Clearmind Medicine Completes Dosing in First 4 Cohorts of Phase I/II Alcohol Use Disorder Trial
Jun 16, 11:55 AM · MT Newswires
Top Premarket Decliners
Jun 1, 11:36 AM · MT Newswires
FDA Fast-Tracks Psychedelic Drug Research Following Trump Directive; Psychedelic Drug Makers Gain
Apr 24, 2:19 PM · MT Newswires
Clearmind Medicine Says Drug Candidate Met Primary Endpoint in Phase I/IIa Trial to Treat Alcohol Use Disorder
Apr 20, 12:28 PM · MT Newswires
Stay on top of CMND
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
